PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 201 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $322,000 | -6.9% | 8,643 | -23.4% | 0.13% | -11.1% |
| Q4 2016 | $346,000 | -39.2% | 11,278 | +32.9% | 0.14% | -43.8% |
| Q3 2016 | $569,000 | +17.3% | 8,488 | -47.9% | 0.26% | +18.0% |
| Q2 2016 | $485,000 | +2.5% | 16,288 | +1.2% | 0.22% | +2.8% |
| Q1 2016 | $473,000 | -26.9% | 16,098 | +95.1% | 0.21% | -25.4% |
| Q4 2015 | $647,000 | +6.4% | 8,253 | +2.4% | 0.28% | +7.2% |
| Q3 2015 | $608,000 | +32.5% | 8,063 | +105.1% | 0.26% | +23.9% |
| Q2 2015 | $459,000 | +85.8% | 3,931 | +276.2% | 0.21% | +79.0% |
| Q1 2015 | $247,000 | – | 1,045 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $13,338,000 | 2.17% |
| Camber Capital Management LP | 2,555,000 | $26,214,000 | 0.92% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,959,741 | $40,627,000 | 0.80% |
| Palo Alto Investors LP | 1,373,897 | $14,096,000 | 0.74% |
| Sofinnova Investments, Inc. | 629,650 | $6,460,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 604,937 | $6,207,000 | 0.22% |
| J. Goldman & Co LP | 238,617 | $2,448,000 | 0.12% |
| GLOBEFLEX CAPITAL L P | 55,027 | $565,000 | 0.12% |
| FRED ALGER MANAGEMENT, LLC | 3,416,003 | $35,048,000 | 0.09% |
| JUPITER ASSET MANAGEMENT LTD | 728,440 | $7,474,000 | 0.08% |